Agilent ZORBAX Eclipse XDB-C18 HPLC Application Note Methotrexate Analysis

This application note describes a HPLC method for the analysis of methotrexate. The method uses a 10/90 acetonitrile/pH 6.0 phosphate/citrate buffer mobile phase and a ZORBAX Eclipse XDB-C18 column, column dimensions 3.9 x 300 mm, particle size 10 µm.


Agilent ZORBAX Eclipse XDB-C18 HPLC Application Note Methotrexate Analysis - cover page
Brand
Agilent
Document type
Product Leaflet
Language
English
Pages
2
File format
PDF
File size
268 KB
Published
03 July, 2012
Updated
30 September, 2023
MD5 checksum
E604DBBCB7A4FB8A91B23A8D75A1EE07

About this manual

This document describes an application for High-Performance Liquid Chromatography (HPLC) analyzing Methotrexate according to United States Pharmacopeia (USP) standards. It highlights the performance of the ZORBAX Eclipse XDB-C18 column as a modern alternative to older L1 columns, specifically noting improvements in peak shape and efficiency.

What's inside

  • Pharmaceutical Application
  • ZORBAX Eclipse XDB-C18 Column
  • USP Method for Methotrexate
  • Comparison with Original L1 Column
  • Chromatographic Conditions

Specifications

Column Particle Size3.5 and 5.0 um
Mobile Phase Ratio10:90 ACN : Buffer
Flow Rate (Original)2.0 ml/min
Column Dimensions (Modern)4.6 x 150 mm
Flow Rate (Modern)1 mL/min
Detection Wavelength302 nm

Frequently asked questions

What is the modern alternative to the older L1 column?

The ZORBAX Eclipse XDB-C18 is available as a state of the art L1 alternative.

What are the benefits of using the ZORBAX Eclipse XDB-C18 column?

Benefits include improved peak shape, higher efficiency, greater sensitivity, reduced analysis time, and reduced back pressure.

How does the resolution compare between the new and old columns?

Resolution is greater on the ZORBAX Eclipse XDB-C18 because the methotrexate peak is much sharper.

Download PDF (268 KB)

More Agilent Manuals


View all Agilent manuals →